Identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (ALL)
How far are we from a cure for CLL?
Drug combinations in CLL: ibrutinib, idelalisib and more
CLL highlights from ASCO 2016: HELIOS trial, CAR T-cell therapy and CLL-IPI
Current news in MCL - allogeneic transplants